Shimada Kazunori, Ito Toshinori, Tanemura Masahiro, Komoda Hiroshi, Fumimoto Yuichi, Kawamoto Koichi, Nishida Toshirou, Kaneto Hideaki, Sawa Yoshiki
Department of Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
J Surg Res. 2008 Apr;145(2):229-37. doi: 10.1016/j.jss.2007.03.030. Epub 2007 Aug 30.
We previously demonstrated the development of beta-cells in the native pancreas after syngeneic pancreas transplantation (PTx) in a model of type 2 diabetes, namely the Spontaneously Diabetic Torii (SDT; RT1 a) rat. In this study, we evaluated the effect of fully allogeneic PTx (allo-PTx) under immunosuppression on the native pancreases in the recipients.
Diabetic 25-week-old SDT rats were divided into two groups: untreated controls and PTx-treated recipients. Dark Agouti (RT1 a) pancreases were then transplanted into the SDT rats. FK506 was administered daily postoperatively. Each group was examined for 15 weeks.
Control SDT rats showed a disappearance of the pancreatic and duodenal homeobox-1 (PDX-1) expression of the pancreases with the development of diabetes. In addition, the islets were gradually replaced by fibrosis, thus resulting in a marked decrease in the beta-cell mass at 40 weeks of age. On the other hand, in PTx recipients, islet-like cell clusters were found in the native pancreases. The beta-cell mass significantly increased in the native pancreases in the recipients at 10 and 15 weeks posttransplantation in comparison to the age-matched controls. Moreover, we observed the re-expression of PDX-1 in the islet-like cell clusters. Interestingly, insulin and glucagon double-positive stained cells in the mesenchyme and insulin single-positive cells in the ductal epithelium were also observed.
Our results indicated that the benefits of avoiding glucose toxicity by allo-PTx under immunosuppression could therefore induce the PDX-1 expression in the native pancreases, thus potentially resulting in the development of beta-cells in type 2 diabetic recipients.
我们之前在2型糖尿病模型,即自发性糖尿病鸟取(SDT;RT1 a)大鼠中,证明了同基因胰腺移植(PTx)后天然胰腺中β细胞的发育。在本研究中,我们评估了免疫抑制下完全异基因PTx(allo-PTx)对受体天然胰腺的影响。
将25周龄的糖尿病SDT大鼠分为两组:未治疗的对照组和PTx治疗的受体组。然后将暗褐鼠(RT1 a)的胰腺移植到SDT大鼠体内。术后每天给予FK506。每组检查15周。
对照SDT大鼠随着糖尿病的发展,胰腺中胰腺十二指肠同源盒-1(PDX-1)表达消失。此外,胰岛逐渐被纤维化取代,因此在40周龄时β细胞量显著减少。另一方面,在PTx受体中,在天然胰腺中发现了胰岛样细胞簇。与年龄匹配的对照组相比,受体天然胰腺中的β细胞量在移植后10周和15周时显著增加。此外,我们观察到胰岛样细胞簇中PDX-1的重新表达。有趣的是,还观察到间充质中胰岛素和胰高血糖素双阳性染色细胞以及导管上皮中的胰岛素单阳性细胞。
我们的结果表明,免疫抑制下allo-PTx避免葡萄糖毒性的益处因此可诱导天然胰腺中PDX-1的表达,从而可能导致2型糖尿病受体中β细胞的发育。